Neurosciences
ROCHESTER, Minn. — An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in[...]
Latest stories
Research
March 4, 2026
Cardiovascular
March 2, 2026
Cancer
February 27, 2026
Research
February 26, 2026
Biotherapeutics
February 25, 2026
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community